Skip to main content
. 2021 Jan 12;41(1):BSR20203857. doi: 10.1042/BSR20203857

Table 3. Bioactivity prediction of the selected inhibitor against L. donovani by molinspiration.

Ligand GPCR ligand Ion channel modulator Kinase inhibitor Nuclear receptor ligand Protease inhibitor Enzyme inhibitor
Cynaroside 0.09 −0.02 0.15 0.27 −0.01 0.42